Medication, lifestyle program or surgery: which route fits your BMI
Whether you should start with a lifestyle program, a GLP-1 medication or bariatric surgery depends mainly on two things: your BMI and the health conditions that come with it. With a BMI of 25 to 29.9 and no weight-related conditions, a structured lifestyle program comes first. At a BMI of 30 or higher, or 27 or higher with a condition such as high blood pressure or type 2 diabetes, you meet the FDA label criteria for medications like Wegovy and Zepbound; at a BMI of 35 or higher, or 30 to 34.9 with metabolic disease, the 2022 ASMBS/IFSO guidelines say surgery should be recommended or considered.
These are not separate ladders. Every route sits on the same foundation of food, movement, sleep and follow-up. What changes is how much medical support you add on top.
| Your situation | Route the evidence points to | Where that comes from |
|---|---|---|
| BMI 25 to 29.9, no weight-related conditions | Structured lifestyle program | Below FDA medication criteria |
| BMI 27 or higher with a weight-related condition | Lifestyle plus anti-obesity medication | FDA Wegovy and Zepbound labels |
| BMI 30 or higher | Lifestyle plus anti-obesity medication | FDA Wegovy and Zepbound labels |
| BMI 30 to 34.9 with metabolic disease | Medication, with surgery considered | ASMBS/IFSO 2022 |
| BMI 35 or higher | Surgery recommended; medication also an option | ASMBS/IFSO 2022 |
BMI 25 to 29.9 with no health conditions: start with lifestyle
If your BMI sits in the overweight range and your blood pressure, blood sugar and cholesterol are healthy, a lifestyle program is the right first move. That is not a consolation prize. It is where the evidence starts, and it is also the base every medication label builds on.
A good lifestyle program is more than a diet app. Look for:
- A calorie target built around protein, so you lose fat rather than muscle
- Resistance training at least a few days a week
- Regular weigh-ins and check-ins with a real person
- Attention to sleep and stress, which drive appetite more than most people expect
- Lab work at the start, so you know your numbers are actually healthy
That last point matters. Plenty of people with a BMI of 28 assume they have no conditions because nothing hurts. Blood work is how you find out. If your labs show early insulin resistance or high triglycerides, you may move into the next tier.
BMI 27 or higher with a condition, or 30 or higher: you qualify for medication
The FDA Wegovy (semaglutide) and Zepbound (tirzepatide) labels set the same eligibility line for chronic weight management in adults: a BMI of 30 or higher, or a BMI of 27 or higher with at least one weight-related condition. The labels give examples such as high blood pressure, abnormal cholesterol, type 2 diabetes, obstructive sleep apnea and cardiovascular disease.
Both labels also say the medication is used as an adjunct to a reduced-calorie diet and increased physical activity. In other words, the FDA approved these drugs on top of lifestyle change, not instead of it. In the clinical trials summarized on each label, people on the medication lost substantially more weight on average than people on placebo, and results varied widely from person to person.
A few label details worth knowing:
- Wegovy also carries an indication to reduce the risk of major adverse cardiovascular events, such as heart attack and stroke, in adults with established cardiovascular disease and either obesity or overweight.
- Zepbound is also approved to treat moderate to severe obstructive sleep apnea in adults with obesity.
- Both labels carry a boxed warning about thyroid C-cell tumors seen in rodents, and both drugs are not for people with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2.
- Nausea, diarrhea, vomiting and constipation are common, especially while the dose is increasing. Doses start low and step up for that reason.
At BioCure, our medical weight loss program uses semaglutide and tirzepatide with weekly injections, escalating doses and then maintenance. It requires a physician consultation and a blood panel before anything is prescribed, and it includes regular check-ins and maintenance support after you reach your goal.
BMI 35 or higher, or 30 with metabolic disease: surgery belongs in the conversation
The 2022 ASMBS/IFSO guidelines on indications for metabolic and bariatric surgery updated decades-old criteria. They recommend surgery for adults with a BMI of 35 or higher, regardless of whether they have other conditions. They also say surgery should be considered for adults with a BMI of 30 to 34.9 who have metabolic disease, such as type 2 diabetes. The same guidelines note that BMI thresholds should be adjusted lower for people of Asian descent, because health risk appears at lower BMI in that population.
According to the NIDDK, the main operations include sleeve gastrectomy, gastric bypass, adjustable gastric banding and biliopancreatic diversion with duodenal switch. Each changes your digestive system, and NIDDK is clear that long-term success depends on lasting changes to how you eat and move, plus lifelong medical follow-up.
Qualifying for surgery does not mean you must have it. Many people with a BMI of 35 or higher start with medication, and some go on to surgery later. The honest answer is that surgery is the most intensive option, with real recovery time and surgical risk, and it is the route the guidelines point to when the medical stakes are highest. That decision belongs with a bariatric surgery team.
Three scenarios: which route fits
Numbers on a chart only go so far. Here is how the criteria play out for three people we often hear from.
A 45-year-old with prediabetes
Say your BMI is 29 and your labs show prediabetes. The FDA labels list conditions like type 2 diabetes and abnormal cholesterol as examples; prediabetes is not on that example list, so whether medication makes sense at a BMI of 29 is a clinical judgment based on your whole picture. A structured lifestyle program is a strong first step, and prediabetes is one of the situations where lifestyle change has the most to offer. If your BMI is 30 or higher, you meet the label criteria with or without a second condition, and medication alongside lifestyle is a reasonable conversation. Repeat labs in a few months tell you whether the plan is working.
A 60-year-old with sleep apnea
Say your BMI is 33 and you have been diagnosed with moderate obstructive sleep apnea. You qualify for weight management medication on BMI alone, and Zepbound is the one drug with a specific FDA indication for moderate to severe sleep apnea in adults with obesity. That makes it a natural option to discuss. It does not replace your sleep doctor or your CPAP; it is added to that care. If your BMI were 35 or higher, the ASMBS/IFSO guidelines would also recommend you be evaluated for surgery.
A post-menopausal woman worried about muscle and bone
Say you are 58, your BMI is 31 and you are worried that losing weight will cost you muscle and bone. That concern is legitimate. Any weight loss, with or without medication, includes some lean tissue, and women already lose muscle faster after midlife (we cover why in 7 reasons women over 40 lose muscle twice as fast as men). You qualify for medication, but the plan should protect what you want to keep: adequate protein, progressive resistance training, a slower rate of loss and a conversation with your clinician about bone density testing. Baseline hormone levels help here too, since menopause changes the picture.
How your lab results change the plan
BMI tells you which doors are open. Your blood work tells you which one to walk through first.
| Marker | What it can reveal | How it can change the plan |
|---|---|---|
| Hemoglobin A1c and fasting glucose | Prediabetes or type 2 diabetes | Can move you into medication or surgery criteria |
| Lipid panel | High LDL or triglycerides | Counts as a weight-related condition on the FDA labels |
| Thyroid panel | Underactive thyroid | Treatable cause of weight gain to address first |
| Sex hormones (testosterone, estradiol) | Low levels or menopausal changes | Affects muscle, energy and how you respond to the plan |
| Liver and kidney markers | Fatty liver or reduced function | Shapes medication choice and monitoring |
A decade ago, most people started a weight loss drug with nothing more than a scale reading. That is no longer good enough. BioCure's comprehensive male and female panels cover hormones, thyroid, lipids, metabolic and organ markers, and the site describes a 90+ biomarker panel. Testing is done with an at-home kit and an in-home phlebotomist, or in a lab, with results in 7 to 14 days. Every result is reviewed with you one on one, and the same markers are rechecked to show whether the plan is working.
How to judge a medical weight loss program
If you are asking which medical weight loss programs actually deliver results, the better question is which program matches your tier. Here is a fair look at the main types.
| Program type | Examples | Best fit | How pricing works |
|---|---|---|---|
| Commercial lifestyle program | WeightWatchers | BMI 25 to 29.9, wants structure and community | Subscription; check the program's site for current plans |
| Digital diabetes prevention | Omada Health | Prediabetes, often offered through an employer or health plan | Often covered by employer or insurer |
| Telehealth GLP-1 services | Ro, Found, Calibrate, Form Health | Meets FDA criteria, wants convenience | Usually cash-pay membership; medication and labs may be separate; check each site |
| Academic weight centers | Mass General, Duke Health, Johns Hopkins | Complex cases, surgery candidates | Typically billed to insurance |
| Physician-led clinic with in-depth labs | BioCure Health | Wants a full baseline panel, a physician and ongoing monitoring | Cash-pay; $199 physician consult credited toward a membership; HSA/FSA documentation provided |
Whatever you choose, look for physician oversight, lab work before prescribing, a plan for side effects, and a plan for after you reach your goal. BioCure is a fit if you want a physician-led program with a detailed baseline panel and follow-up included, by video or in person in South Florida, and we treat patients in 47 states. If you need surgery or want to use insurance, an academic center is the better fit. BioCure does not accept insurance directly, and membership pricing depends on your protocol and is set at your consultation.
Frequently asked questions
What BMI do I need to qualify for Wegovy or Zepbound?
The FDA labels for both drugs cover adults with a BMI of 30 or higher, or 27 or higher with at least one weight-related condition such as high blood pressure, abnormal cholesterol or type 2 diabetes. Both are meant to be used with a reduced-calorie diet and more physical activity. A clinician still has to confirm the medication is safe for you.
What BMI do you need for bariatric surgery in 2026?
The 2022 ASMBS/IFSO guidelines recommend surgery for adults with a BMI of 35 or higher, regardless of other conditions. They say surgery should be considered for adults with a BMI of 30 to 34.9 who have metabolic disease, with lower thresholds for people of Asian descent. Your insurance plan may use its own criteria.
Is a GLP-1 better than bariatric surgery?
Neither is better for everyone. Surgery is the most intensive option and is recommended at the highest BMI and risk levels, while medication suits a wider range of people and requires ongoing treatment. Many people start with medication and revisit surgery if they need more.
Can I take a GLP-1 if my BMI is under 27?
That falls outside the FDA labeled use for chronic weight management with Wegovy and Zepbound. At that range, a structured lifestyle program is the evidence-based starting point. Lab work can confirm whether there is a medical issue worth addressing.
Will I lose muscle on semaglutide or tirzepatide?
Any weight loss includes some lean tissue, so protecting muscle should be part of the plan. Adequate protein, regular resistance training and a steady rate of loss all help. This matters most for women after menopause and for older adults.
Do I need blood work before starting a weight loss medication?
A responsible program checks your labs first. A1c, lipids, thyroid, liver, kidney and hormone markers can change which medication fits and how closely you are monitored. BioCure requires a blood panel before prescribing semaglutide or tirzepatide.
Your BMI opens the door, your labs choose the route, and your daily habits decide how far it takes you. Weight loss that lasts is not accidental, it is intentional.
Let BioCure Health lead you in the right direction. Call or text us to schedule an introductory call at 754-206-0838, your future self will thank you.